Michael Minnicozzi

2.1k total citations
35 papers, 1.5k citations indexed

About

Michael Minnicozzi is a scholar working on Physiology, Immunology and Allergy and Molecular Biology. According to data from OpenAlex, Michael Minnicozzi has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 9 papers in Immunology and Allergy and 7 papers in Molecular Biology. Recurrent topics in Michael Minnicozzi's work include Asthma and respiratory diseases (22 papers), Allergic Rhinitis and Sensitization (7 papers) and Food Allergy and Anaphylaxis Research (5 papers). Michael Minnicozzi is often cited by papers focused on Asthma and respiratory diseases (22 papers), Allergic Rhinitis and Sensitization (7 papers) and Food Allergy and Anaphylaxis Research (5 papers). Michael Minnicozzi collaborates with scholars based in United States, United Kingdom and Japan. Michael Minnicozzi's co-authors include Robert W. Egan, Richard W. Chapman, William Kreutner, John A. Hey, T T Kung, Gerald J. Gleich, Robert P. Schleimer, Serpil C. Erzurum, Stanley J. Szefler and Robert G. Hamilton and has published in prestigious journals such as The Journal of Immunology, Biochemical and Biophysical Research Communications and Journal of Allergy and Clinical Immunology.

In The Last Decade

Michael Minnicozzi

35 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Minnicozzi United States 23 833 502 416 286 256 35 1.5k
Shahin Sanjar United States 21 985 1.2× 679 1.4× 362 0.9× 218 0.8× 425 1.7× 64 1.8k
Joan E. Loader United States 25 697 0.8× 403 0.8× 428 1.0× 240 0.8× 304 1.2× 50 1.6k
Ingrid van Ark Netherlands 20 1.1k 1.3× 427 0.9× 634 1.5× 327 1.1× 264 1.0× 49 1.7k
Stéphane Kirkesseli United States 11 851 1.0× 466 0.9× 354 0.9× 335 1.2× 92 0.4× 16 1.3k
C M Lilly United States 18 1.1k 1.3× 546 1.1× 357 0.9× 142 0.5× 201 0.8× 26 1.7k
R. Robert Schellenberg Canada 29 1.4k 1.7× 992 2.0× 360 0.9× 544 1.9× 345 1.3× 91 2.5k
J. A. M. Raaijmakers Netherlands 17 409 0.5× 192 0.4× 417 1.0× 167 0.6× 318 1.2× 44 1.3k
Michael McLane United States 22 446 0.5× 264 0.5× 413 1.0× 97 0.3× 557 2.2× 54 1.8k
Gregory S. Whitehead United States 22 1.0k 1.2× 398 0.8× 1.0k 2.5× 260 0.9× 336 1.3× 50 2.1k
Giuseppina Chiappara Italy 23 1.0k 1.2× 882 1.8× 546 1.3× 231 0.8× 429 1.7× 50 2.0k

Countries citing papers authored by Michael Minnicozzi

Since Specialization
Citations

This map shows the geographic impact of Michael Minnicozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Minnicozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Minnicozzi more than expected).

Fields of papers citing papers by Michael Minnicozzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Minnicozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Minnicozzi. The network helps show where Michael Minnicozzi may publish in the future.

Co-authorship network of co-authors of Michael Minnicozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Minnicozzi. A scholar is included among the top collaborators of Michael Minnicozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Minnicozzi. Michael Minnicozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Platts‐Mills, Thomas A.E., Scott P. Commins, Tilo Biedermann, et al.. (2020). On the cause and consequences of IgE to galactose-α-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat Allergy. Journal of Allergy and Clinical Immunology. 145(4). 1061–1071. 92 indexed citations
2.
Spergel, Amanda K. Rudman, Michael Minnicozzi, Lisa M. Wheatley, & Alkis Togias. (2018). Is Allergen Immunotherapy in Children Disease Modifying? A Review of the Evidence. Current Allergy and Asthma Reports. 18(9). 47–47. 11 indexed citations
3.
Krishnan, Jerry A., Robert F. Lemanske, Glorisa Canino, et al.. (2012). Asthma outcomes: Symptoms. Journal of Allergy and Clinical Immunology. 129(3). S124–S135. 64 indexed citations
4.
Szefler, Stanley J., Sally E. Wenzel, Robert H. Brown, et al.. (2012). Asthma outcomes: Biomarkers. Journal of Allergy and Clinical Immunology. 129(3). S9–S23. 279 indexed citations
5.
Chapman, Richard W., Michael Minnicozzi, Chander Celly, et al.. (2007). A Novel, Orally Active CXCR1/2 Receptor Antagonist, Sch527123, Inhibits Neutrophil Recruitment, Mucus Production, and Goblet Cell Hyperplasia in Animal Models of Pulmonary Inflammation. Journal of Pharmacology and Experimental Therapeutics. 322(2). 486–493. 116 indexed citations
6.
Sawyer, Richard T., Peter J. Gergen, Michael Minnicozzi, et al.. (2006). The future of immunotherapy. Report of a National Institute of Allergy and Infectious Diseases (NIAID), Division of Allergy, Immunology and Transplantation (DAIT) Workshop. Allergy. 61(10). 1159–1161. 4 indexed citations
7.
Chorley, Brian N., Anne L. Crews, Yuehua Li, et al.. (2006). Differential Muc2 and Muc5ac secretion by stimulated guinea pig tracheal epithelial cells in vitro. Respiratory Research. 7(1). 35–35. 11 indexed citations
8.
Phillips, Jonathan E., et al.. (2005). An enzyme-linked immunosorbent assay (ELISA) for the determination of mucin levels in bronchoalveolar lavage fluid. Journal of Pharmacological and Toxicological Methods. 53(2). 160–167. 10 indexed citations
9.
Chapman, Richard W., Yvette Crawley, Robert W. Egan, et al.. (2003). Inhibition of experimental acute pulmonary inflammation by pirfenidone. Pulmonary Pharmacology & Therapeutics. 16(4). 207–214. 44 indexed citations
10.
Billah, Motasim, George M. Buckley, Nicola J. Cooper, et al.. (2002). 8-Methoxyquinolines as PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(12). 1617–1619. 18 indexed citations
11.
Billah, M. Motasim, Nicola J. Cooper, Michael Minnicozzi, et al.. (2002). Pharmacology of N-(3,5-Dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline Carboxamide (SCH 351591), a Novel, Orally Active Phosphodiesterase 4 Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 302(1). 127–137. 27 indexed citations
12.
Chapman, Richard W., Jay S. Fine, H. Jones, et al.. (2001). Comparison of PDE 4 Inhibitors, Rolipram and SB 207499 (ArifloTM, in a Rat Model of Pulmonary Neutrophilia. Pulmonary Pharmacology & Therapeutics. 14(2). 157–164. 48 indexed citations
13.
Kung, Ted T., Bin Luo, Yvette Crawley, et al.. (2001). Effect of Anti-mIL-9 Antibody on the Development of Pulmonary Inflammation and Airway Hyperresponsiveness in Allergic Mice. American Journal of Respiratory Cell and Molecular Biology. 25(5). 600–605. 64 indexed citations
14.
Chapman, Reg, Charles G. Garlisi, Angela Falcone, et al.. (1996). 685 Effect of inhaled mometasone furoate on inflammatory cell influx and cytokine levels in the lungs of allergic mice. Journal of Allergy and Clinical Immunology. 97(1). 354–354. 3 indexed citations
15.
Minnicozzi, Michael, et al.. (1995). Polyarginine and Eosinophil-Derived Major Basic Protein Increase Microvascular Permeability Independently of Histamine or Nitric Oxide Release. Microvascular Research. 50(1). 56–70. 11 indexed citations
16.
Minnicozzi, Michael, G.J. Gleich, Walter N. Durán, & Robert W. Egan. (1995). Increased Microvascular Permeability Induced by Eosinophil Proteins. International Archives of Allergy and Immunology. 107(1-3). 348–348. 2 indexed citations
17.
Minnicozzi, Michael, Walter N. Durán, Donghyun Kim, et al.. (1995). Tissue eosinophilia induced by recombinant human interleukin‐5 in the hamster cheek pouch membrane. Mediators of Inflammation. 4(5). 331–338. 1 indexed citations
18.
Minnicozzi, Michael, Walter N. Durán, Gerald J. Gleich, & Robert W. Egan. (1994). Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch.. The Journal of Immunology. 153(6). 2664–2670. 53 indexed citations
19.
Minnicozzi, Michael, John C. Anthes, Marvín I. Siegel, M. Motasim Billah, & Robert W. Egan. (1990). Activation of phospholipase D in normodense human eosinophils. Biochemical and Biophysical Research Communications. 170(2). 540–547. 22 indexed citations
20.
Gulbenkian, A., Xiomara Fernandez, William Kreutner, et al.. (1990). Anaphylactic Challenge Causes Eosinophil Accumulation in Bronchoalveolar Lavage Fluid of Guinea Pigs: Modulation by Betamethasone, Phenidone, Indomethacin, WEB 2086, and a Novel Antiallergy Agent, SCH 37224. American Review of Respiratory Disease. 142(3). 680–685. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026